story of the week
GLP-1 Receptor Agonist and Basal Insulin Combination Effective for T2DM Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet